Launch in Europe
UNISTRAIN® PRRS was presented at Edinburgh in 2013 within the framework of the ESPHM. The arrival of UNISTRAIN® PRRS provided an efficient alternative to European producers to better control PRRS with a live vaccine with potent immunogenic features and safety proved fulfilling all the EMA requirements.
Combination with ERYSENG® PARVO
The first and unique combination of a PRRS live vaccine and a bivalent Erysipelas and porcine parvovirus vaccine was registered in Europe in 2014. This combination provides to the market a convenient and welfare-friendly vaccination to cover 3 of the most important reproductive diseases for the breeding herd.
Birth of prrscontrol.com
PRRS is the trickiest disease with the highest economic impact in the swine industry. Prrscontrol.com was born to provide high quality and updated technical information to approach PRRS. Knowledge, video tutorials, experts answering questions and tools to control PRRS are the key contents you can find in.
Launch of Hipradermic®
With the official registration of the intradermal route for UNISTRAIN® PRRS, HIPRA presented the ID needle-free device for UNISTRAIN® PRRS: Hipradermic®. With this innovative device, HIPRA started the way of animal welfare, vaccination traceability, quality vaccination and better immunity that represents a step forward on PRRS control. Hipradermic® is an end to end project completely made by HIPRA.
In-house sequencing service at Diagnos
In 2018, due to the growing demand for a deeper understanding of PRRSV epidemiology, HIPRA ceased outsourcing sequencing services and established an in-house, high-quality ORF5 sequencing service for our customers. This initiative entailed a significant investment in equipment, facilities, personnel and training.
Combination with AUSKIPRA® GN
The first and unique combination of two live vaccines, PRRS and Aujeszky vaccine, was registered. Moreover, this was the first combination that can be administered by both ID and IM route. This innovative combination provides to the market a convenient and welfare-friendly vaccination to cover two major swine diseases.
ORF2-7 sequencing at Diagnos
Arrival in Japan
At the beginning of 2023, HIPRA got the marketing authorization of UNISTRAIN® PRRS in Japan. This confirms UNISTRAIN® PRRS as a useful tool for controlling PRRS in Asia and demonstrates the cross-protection capacity of UNISTRAIN® PRRS against any type of PRRS viruses.